Smart implants for delivering therapeutic proteins to treat hemophilia A
SMART BIOELECTRONIC IMPLANTS FOR CONTROLLED DELIVERY OF THERAPEUTIC PROTEINS IN VIVO AND ITS APPLICATION IN LONG-TERM TREATMENT OF HEMOPHILIA A
This study is exploring a new type of implant that can safely deliver helpful proteins to people with hemophilia A, aiming to provide a long-lasting and effective treatment while keeping the body’s immune system from attacking it.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-11014418 on NIH RePORTER |
What this research studies
This research focuses on developing advanced bioelectronic implants that can deliver therapeutic proteins in a controlled manner for the long-term treatment of hemophilia A. The approach involves encapsulating engineered cells that produce these proteins within a device that protects them from the immune system while allowing necessary nutrients and oxygen to reach the cells. By integrating electronic components into the implant, the researchers aim to enhance its functionality and longevity, addressing challenges such as inflammation and inadequate nutrient supply. This innovative method could provide a more effective and sustainable treatment option for patients with hemophilia A.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with hemophilia A who require ongoing treatment to manage their condition.
Not a fit: Patients with other bleeding disorders or those who do not have hemophilia A may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a breakthrough treatment for hemophilia A, reducing the need for frequent injections and improving patients' quality of life.
How similar studies have performed: While the concept of cell encapsulation has been explored, this specific approach integrating bioelectronics is novel and has not been extensively tested in humans.
Where this research is happening
Cambridge, United States
- Massachusetts Institute of Technology — Cambridge, United States (Active)
Researchers
- Principal investigator: Anderson, Daniel G — Massachusetts Institute of Technology
- Study coordinator: Anderson, Daniel G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.